Literature DB >> 9046054

Amplification of inhibitory mechanisms in cerebral ischemia: an alternative approach to neuronal protection.

A Shuaib1, R Kanthan.   

Abstract

The central nervous system consumes 20% of the cardiac output for normal function. The neurons are very sensitive to the effects of ischemia. Cessation of cerebral blood flow results in severe damage to neurons and other brain structures. This is secondary to a combination of energy loss, excessive excitation promoting intracellular calcium (Ca2+) buildup, relative lack of inhibitory responses, generation of oxygen free radicals (especially during the reperfusion period) and several other destructive cascades. Medications that antagonize the effects of glutamate at post-synaptic receptors are either ineffective or have serious side-effects. Ca2+ entry blockers have shown disappointing results in clinical trials in patients with acute cerebral infarction. Data with protective effects of oxygen free radical scavengers in the post-ischemic period have shown conflicting results. There is recent interest with the use of agents that increase cerebral inhibitory responses after an ischemic insult. Such agents are effective when used before, during or up to 4 hours after the ischemic insult. Many such medications have few side-effects and are in clinical use for other indications. This review will summarize inhibitory mechanisms that may be important in cerebral ischemia, and provide experimental evidence for their potential efficacy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9046054

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  10 in total

Review 1.  Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Faqi Li
Journal:  Curr Neurovasc Res       Date:  2005-12       Impact factor: 1.990

2.  Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?

Authors:  Glen B Baker; Bernard Sowa; Kathryn G Todd
Journal:  J Psychiatry Neurosci       Date:  2007-09       Impact factor: 6.186

3.  Effect of diazepam on the contents of amino acids and free radical during ischemia/reperfusion injury.

Authors:  B Hu; Y Mei; G Wei; X Qiu; S Sun; E Tong
Journal:  J Tongji Med Univ       Date:  2001

4.  Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.

Authors:  Erin M MacKenzie; Suzanne L Grant; Glen B Baker; Paul L Wood
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

Review 5.  Therapeutic promise and principles: metabotropic glutamate receptors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  Oxid Med Cell Longev       Date:  2008 Oct-Dec       Impact factor: 6.543

6.  Enhancement of inhibitory synaptic transmission in large aspiny neurons after transient cerebral ischemia.

Authors:  Y Li; Z Lei; Z C Xu
Journal:  Neuroscience       Date:  2009-01-03       Impact factor: 3.590

7.  The Gliopeptide ODN, a Ligand for the Benzodiazepine Site of GABAA Receptors, Boosts Functional Recovery after Stroke.

Authors:  Rhita Lamtahri; Mahmoud Hazime; Emma K Gowing; Raghavendra Y Nagaraja; Julie Maucotel; Michael Alasoadura; Pascale P Quilichini; Katia Lehongre; Benjamin Lefranc; Katarzyna Gach-Janczak; Ann-Britt Marcher; Susanne Mandrup; David Vaudry; Andrew N Clarkson; Jérôme Leprince; Julien Chuquet
Journal:  J Neurosci       Date:  2021-07-01       Impact factor: 6.167

Review 8.  Neurovascular interaction and the pathophysiology of diabetic retinopathy.

Authors:  Haohua Qian; Harris Ripps
Journal:  Exp Diabetes Res       Date:  2011-02-21

9.  Nutritional regulation of glutathione in stroke.

Authors:  P G Paterson; B H Juurlink
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

Review 10.  Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine.

Authors:  Dmitriy Matveychuk; Erin M MacKenzie; David Kumpula; Mee-Sook Song; Andrew Holt; Satyabrata Kar; Kathryn G Todd; Paul L Wood; Glen B Baker
Journal:  Cell Mol Neurobiol       Date:  2021-04-10       Impact factor: 5.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.